POMBILITI 105 mg, poudre pour solution à diluer pour perfusion — 1 flacon en verre de 20 mL
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930272619 -
CIP7
3027261 -
CIS
64427538 -
Registration number
EU/1/22/1714
What the source publishes
- Holder
- AMICUS THERAPEUTICS EUROPE (IRLANDE)
- Active ingredients
- CIPAGLUCOSIDASE ALFA
- Form
- poudre pour solution à diluer pour perfusion
- Package
- 1 flacon en verre de 20 mL
- Routes
- intraveineuse
- Administrative status
- authorised
- Supply regime
- prescription hospitalière ; liste I ; les premières administrations doivent être effectuées en milieu hospitalier
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2023-03-20
- Prescription
- Prescription or restricted
Names this record is found by
- POMBILITI 105 mg, poudre pour solution à diluer pour perfusion — 1 flacon en verre de 20 mL
- POMBILITI 105 mg, poudre pour solution à diluer pour perfusion
- CIPAGLUCOSIDASE ALFA
Complete source data
{
"cis": "64427538",
"cip7": "3027261",
"form": "poudre pour solution à diluer pour perfusion",
"name": "POMBILITI 105 mg, poudre pour solution à diluer pour perfusion — 1 flacon en verre de 20 mL",
"cip13": "3400930272619",
"holder": "AMICUS THERAPEUTICS EUROPE (IRLANDE)",
"routes": [
"intraveineuse"
],
"holders": [
"AMICUS THERAPEUTICS EUROPE (IRLANDE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2023-03-20",
"compositions": [
{
"name": "CIPAGLUCOSIDASE ALFA",
"nature": "SA",
"strength": "105 mg",
"linkageNumber": "1",
"substanceCode": "39982",
"dosageReference": "un flacon",
"pharmaceuticalElement": "poudre"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "prescription hospitalière ; liste I ; les premières administrations doivent être effectuées en milieu hospitalier",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "POMBILITI 105 mg, poudre pour solution à diluer pour perfusion",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "1 flacon en verre de 20 mL",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2023-11-09",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": true,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CIPAGLUCOSIDASE ALFA"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"prescription hospitalière",
"liste I",
"les premières administrations doivent être effectuées en milieu hospitalier"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/22/1714",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930272619"